A novel molecular mechanism of microRNA‐21 inducing pulmonary fibrosis and human pulmonary fibroblast extracellular matrix through transforming growth factor β1–mediated SMADs activation-Reference-Cited by-同舟云学术

A novel molecular mechanism of microRNA‐21 inducing pulmonary fibrosis and human pulmonary fibroblast extracellular matrix through transforming growth factor β1–mediated SMADs activation

Published:2018-06-26 Issue:9 Volume:119 Page:7834-7843
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Zhou Jun¹,Xu Qianqian¹,Zhang Qiudi¹,Wang Zhigang¹,Guan Shuhong¹^ORCID

Affiliation:

1. Department of Respiratory Medicine The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou Changzhou China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27185

Reference33 articles.

1. Immune Mechanisms in Pulmonary Fibrosis

2. MicroRNAs as potential targets for progressive pulmonary fibrosis

3. Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21

4. MicroRNA profiling implicates the insulin-like growth factor pathway in bleomycin-induced pulmonary fibrosis in mice

5. The evolution of gene regulation by transcription factors and microRNAs

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silica nanoparticles triggered epithelial ferroptosis via miR-21-5p/GCLM signaling to contribute to fibrogenesis in the lungs;Chemico-Biological Interactions;2024-08

2. Advances in the Study of Non-Coding RNA in the Signaling Pathway of Pulmonary Fibrosis;International Journal of General Medicine;2024-04

3. MicroRNA in Fibrotic Disorders: A Potential Target for Future Therapeutics;Frontiers in Bioscience-Landmark;2023-11-29

4. Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis;Respiratory Research;2023-04-15

5. Epigenetics of the pathogenic myofibroblast in lung disease;Epigenetics in Organ Specific Disorders;2023